MBA Advisors
ABBV icon

MBA Advisors’s AbbVie ABBV Stock Holding History

MBA Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.58M Buy
6,047
+77
+1% +$19.7K 0.52% 37
2026
Q2 		$1.5M Buy
5,970
+163
+3% +$35.1K 0.51% 43
2026
Q1 		$1.26M Buy
5,807
+679
+13% +$151K 0.49% 45
2025
Q4 		$1.17M Sell
5,128
-92
-2% -$21K 0.47% 47
2025
Q3 		$1.21M Sell
5,220
-405
-7% -$82.5K 0.52% 42
2025
Q2 		$1.04M Sell
5,625
-215
-4% -$40K 0.48% 49
2025
Q1 		$1.22M Buy
5,840
+96
+2% +$18.7K 0.61% 37
2024
Q4 		$1.02M Sell
5,744
-486
-8% -$89.4K 0.51% 47
2024
Q3 		$1.23M Buy
6,230
+12
+0.2% +$2.24K 0.59% 43
2024
Q2 		$1.07M Buy
6,218
+495
+9% +$82K 0.55% 45
2024
Q1 		$1.04M Sell
5,723
-423
-7% -$72.9K 0.54% 48
2023
Q4 		$952K Sell
6,146
-135
-2% -$19.7K 0.53% 47
2023
Q3 		$936K Buy
6,281
+19
+0.3% +$2.79K 0.57% 45
2023
Q2 		$844K Buy
6,262
+41
+0.7% +$6.01K 0.5% 48
2023
Q1 		$991K Buy
6,221
+169
+3% +$25.8K 0.62% 47
2022
Q4 		$978K Buy
6,052
+198
+3% +$30.4K 0.64% 43
2022
Q3 		$786K Buy
5,854
+604
+12% +$86.7K 0.57% 47
2022
Q2 		$804K Sell
5,250
-83
-2% -$12.7K 0.55% 51
2022
Q1 		$864K Sell
5,333
-786
-13% -$114K 0.54% 54
2021
Q4 		$828K Buy
6,119
+651
+12% +$76.9K 0.51% 54
2021
Q3 		$590K Buy
5,468
+61
+1% +$6.97K 0.44% 64
2021
Q2 		$609K Sell
5,407
-366
-6% -$41.2K 0.28% 62
2021
Q1 		$625K Buy
+5,773
New +$617K 0.34% 59

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

MBA Advisors's ABBV Position: Q3 2026 in Review

MBA Advisors increased its AbbVie (ABBV) stake by 1.3% in Q3 2026, buying an estimated $19.7K and bringing the position to 6,047 shares worth $1.58M. The position accounts for 0.52% of the portfolio, ranked #37.

MBA Advisors first reported a position in ABBV in Q1 2021 and has held it in 23 quarters since. 3,052 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • MBA Advisors held 6,047 shares of AbbVie worth $1.58M as of Q3 2026.
  • MBA Advisors bought 77 AbbVie shares in Q3 2026, an estimated $19.7K.
  • AbbVie made up 0.52% of MBA Advisors's portfolio in Q3 2026, its #37 holding.
  • MBA Advisors first reported a position in AbbVie in Q1 2021 and has held it in 23 quarters since.
  • 3,052 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on MBA Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.